BioSpace News Archive

The vendor landscape of the global market for refurbished medical imaging equipment features a largely concentrated nature in established regional markets such as Europe and North America, with companies increasingly focusing on expansion in untapped regional markets for better growth prospects, observes Transparency Market Research in a recent report.

Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced the submission of a New Drug Application to the U.S. FDA for ACER-001 for the treatment of Urea Cycle Disorders.

Supply of equipment and samples related to health care and medical requirements can sometimes be urgent and critical. A medical courier allows the movement from one place to another, often from the collection point of things such as blood and urine to the clinics or labs where the tests are to take place.

A dysphagia diet emphasizes the variety of meals and drinks that are easier and safer for patients to swallow.

Transparency Market Research has published a new report titled, “Anal Fistula Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Mission Therapeutics, a drug discovery and development company focused on targeting the ubiquitin pathway, and AbbVie announced progression of selected deubiquitylating enzyme targets into the next phase of research in their neurodegenerative disease collaboration.

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced financial results for its fiscal 2022 first quarter that ended June 30, 2021.

Ra Medical Systems, Inc. announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021.

Eagle Pharmaceuticals, Inc. announced that it has entered into a licensing agreement with AOP Orphan Pharmaceuticals GmbH, a privately owned Austrian company devoted to the treatment of rare and special diseases, for the commercial rights to its product, Landiolol in the United States.

Immunovant, Inc., a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, reported financial results for its fiscal first quarter ended June 30, 2021.